S-Methyl methanesulfonothioate

CAS No. 2949-92-0

S-Methyl methanesulfonothioate( —— )

Catalog No. M35863 CAS No. 2949-92-0

S-Methyl methanesulfonothioate is a biological raw material with cytotoxicity and potential antimicrobial activity for the study of Pseudomonas aeruginosa infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 29 In Stock

Biological Information

  • Product Name
    S-Methyl methanesulfonothioate
  • Note
    Research use only, not for human use.
  • Brief Description
    S-Methyl methanesulfonothioate is a biological raw material with cytotoxicity and potential antimicrobial activity for the study of Pseudomonas aeruginosa infections.
  • Description
    S-Methyl methanesulfonothioate is a biological raw material with cytotoxicity and potential antimicrobial activity for the study of Pseudomonas aeruginosa infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2949-92-0
  • Formula Weight
    126.2
  • Molecular Formula
    C2H6O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CSS(C)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Antibacterial agent ...

    Antibacterial Agent 125 exhibits potent antimicrobial activity against clinically relevant Gram-positive pathogens, displaying Minimum Inhibitory Concentration (MIC) 50 values ranging from 0.25 to 8 μM. It is suitable for researching antimicrobial resistance.

  • Isovalerylshikonin

    Isovalerylshikonin is a natural product from Onosma heterophylla and Arnebia euchroma.

  • GSK-1322322

    A novel antibacterial agent that targets bacterial peptide deformylase; demonstrates in vitro activity against MDR respiratory and skin infection pathogens.